SFX by Ex Libris Inc.

Title:	Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Source:	Nature [0028-0836] Baek, K H yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Winslow, X. "NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21." Nature 441.7093 (2006): 595-600.
description	2.	Klement, D. "Platelet-associated PF-4 as a biomarker of early tumor growth." Blood 111.3 (2007): 1201-1207.
description	3.	Fuentes, J. "DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways." Human molecular genetics 9.11 (2000): 1681-90.
description	4.	Folkman, J. "Opinion - Angiogenesis: an organizing principle for drug discovery?" Nature reviews. Drug discovery 6.4 (2007): 273-286.
description	5.	Dalle-Donne, I. "Protein carbonylation, cellular dysfunction, and disease progression." Journal of cellular and molecular medicine 10.2 (2006): 389-406.
description	6.	Oancea, E. "Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals." Cell 95.3 (1998): 307-18.
description	7.	Folkman, J. "ANGIOGENESIS." Annual review of medicine 57.1 (2006): 1-18.
description	8.	von Degenfeld, G. "Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia." The FASEB journal 20.14 (2007): 2657-9.
description	9.	Crabtree, Gerald R R. "Calcineurin/NFAT Signaling in Osteoblasts Regulates Bone Mass." Developmental cell 10.6 (2006): 771-782.
description	10.	Gwack, Y. "A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT." Nature 441.7093 (2006): 646-650.
description	11.	Nyström, T. "Role of oxidative carbonylation in protein quality control and senescence." The EMBO journal 24.7 (2005): 1311-7.
description	12.	Reeves, Roger H H. "A year of unprecedented progress in Down syndrome basic research." Mental retardation and developmental disabilities research reviews 13.3 (2007): 215-20.
description	13.	Italiano, Joseph E E. "Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released." Blood 111.3 (2008): 1227-1233.
description	14.	Madden LA, Sandström ME, Lovell RJ, McNaughto, L. "Inducible heat shock protein 70 and its role in preconditioning and exercise." Amino acids 34.4 (2007): 511-516.
description	15.	Naumov, George N N. "A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype." Journal of the National Cancer Institute 98.5 (2006): 316-325.
description	16.	Hung, R. "Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model." Journal of proteome research 5.8 (2006): 1866-78.
description	17.	Rothermel, B. "A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling." The Journal of biological chemistry 275.12 (2000): 8719-25.
description	18.	Fuentes, J. "Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene." Genomics 44.3 (1997): 358-61.
description	19.	Kim, Jeong-a A. "Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms." Circulation 113.15 (2006): 1888-904.
description	20.	Alcántara, S. "Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis." Mechanisms of development 101.1 (2001): 289-92.